Mid American Wealth Advisory Group, Inc. Editas Medicine, Inc. Transaction History
Mid American Wealth Advisory Group, Inc.
- $210 Billion
- Q2 2025
A detailed history of Mid American Wealth Advisory Group, Inc. transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Mid American Wealth Advisory Group, Inc. holds 40 shares of EDIT stock, worth $156. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40Holding current value
$156% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding EDIT
# of Institutions
218Shares Held
45.5MCall Options Held
476KPut Options Held
338K-
Black Rock Inc. New York, NY7.78MShares$30.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.16MShares$28.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.96MShares$7.7 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.88MShares$7.36 Million0.0% of portfolio
-
State Street Corp Boston, MA1.85MShares$7.24 Million0.0% of portfolio
About Editas Medicine, Inc.
- Ticker EDIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,737,200
- Market Cap $269M
- Description
- Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...